What do enterprise buyers in healthcare care about most when evaluating AI products?
To answer that question, we interviewed leaders from many of the largest healthcare providers and insurers across the country.
In Part A, we outlined the paths to generating unique value for the healthcare system and patients. Now, in Part B, we cover capturing and defending some portion of the value you generate.
We’ve designed this to mirror the thought process of an entrepreneur building an AI product with an enterprise use case. Throughout, we’ve integrated insights from the executives we interviewed at many leading healthcare organizations–including Bassett Healthcare Network, Blue Cross Blue Shield of MA, ChenMed, CommonSpirit Health, Marshfield Clinic Health System, Point32Health, Providence, UC Davis Health, and University of Pittsburgh Medical Center (UPMC)–to highlight how their decision criteria for evaluating AI solutions might inform your go-to-market strategy.
To continue reading this article, click here.